RocketTickers

RocketTickers

PFE: Pfizer Inc. 2021-08-30 06:45:00 Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis

RocketTickers

PSTX: Poseida Therapeutics, Inc. 2021-08-30 08:00:00 Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma

RocketTickers

REGN: Regeneron Pharmaceuticals, Inc. 2021-08-24 07:00:00 Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular Degeneration

RocketTickers

CCCC: C4 Therapeutics, Inc. 2021-08-11 16:01:00 C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma

RocketTickers

BSX: Boston Scientific Corporation 2021-08-10 16:00:00 Boston Scientific Receives FDA Clearance for EXALT™ Model B Single-Use Bronchoscope

RocketTickers

FULC: Fulcrum Therapeutics, Inc. 2021-08-10 07:00:00 Fulcrum Therapeutics Announces Positive Interim Results from Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease

RocketTickers

EIGR: Eiger BioPharmaceuticals, Inc. 2021-08-05 08:00:00 Eiger Announces FDA Breakthrough Therapy Designation for Avexitide for Treatment of Congenital Hyperinsulinism

RocketTickers

ALDX: Aldeyra Therapeutics, Inc. 2021-08-04 08:00:00 Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa

RocketTickers

PFE: Pfizer Inc. 2021-08-04 06:45:00 Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata

RocketTickers

BGNE: BeiGene, Ltd. 2021-07-29 20:00:00 BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

RocketTickers

ALNY: Alnylam Pharmaceuticals, Inc. 2021-07-29 07:00:00 Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1

RocketTickers

DRNA: Dicerna Pharmaceuticals, Inc. 2021-07-29 07:30:00 Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder

RocketTickers

ETON: Eton Pharmaceuticals 2021-06-15 10:37:52 Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)

RocketTickers

CLSD: Clearside Biomedical, Inc. 2021-06-15 07:05:00 Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

RocketTickers

BIIB: Biogen Inc. 2021-06-07 13:00:00 FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

RocketTickers

PRTK: Paratek Pharmaceuticals 2021-06-01 07:45:00 Paratek Pharmaceuticals Announces FDA Approval of NUZYRA® (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

RocketTickers

BHVN: Biohaven Pharmaceutical Holding Company Ltd. 2021-05-27 16:00:00 FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment

RocketTickers

AMPH: Amphastar Pharmaceuticals, Inc. 2021-05-03 06:00:00 Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection